Precision Medicine

The director of the All of Us Research Program at the National Institutes of Health draws on hard-won experience as he works to the democratize the potential of genomic research.

While the industry is rapidly making progress on precision medicine, cultural, policy and regulatory changes are limiting momentum, industry leaders said at the Precision Medicine Summit on Monday.

Cited for creativity in technology and artificial intelligence, Green is recognized on this year’s list for alerting businesses to the potential of Watson.

Licensing partnership with 2bPrecise aims to bring genomics into the EHR workflow.

With the goal of enrolling 10,000 Americans by early autumn, Precision Medicine Initiative program head Eric Dishman said that NIH intends to scale up quickly.

The hospital is investing $15 million into its Navican startup to bring its TheraMap software to market so other providers can deliver precision care for their patients, officials said.

WannaCry attacks highlight the dangers of terrorists accessing CRISPR tools, experts say.

The last podcast in this series looks at current opportunities presented by advancements in Precision Medicine. How are healthcare organizations and patients learning to leverage the knowledge locked in our genes? And how can this knowledge become a real opportunity today?

The partnership will offer community hospitals and treatment centers around the world access to Intermountain’s best practices.

While evolving technology is paving the way, high drug costs, limited interoperability and physician skepticism need to be overcome.